In this article we discuss the 5 best dividend stocks according to billionaire Ray Dalio. If you want to read our detailed analysis of Dalio’s history and hedge fund performance, go directly to the 10 Best Dividend Stocks According to Billionaire Ray Dalio.
5. AbbVie Inc. (NYSE: ABBV)
Percent of Ray Dalio’s 13F Portfolio: 0.02%
No. of Hedge Fund Holders: 83
AbbVie Inc. (NYSE:ABBV) is a U.S-based pharmaceutical company that has been around since 2013. AbbVie’s drug Humira (adalimumab) received Health Canada’s greenlight for treating ulcerative colitis in children over 5 years old.
In Europe, the EMA has a positive opinion about using a drug combination of Venclyxto (venetoclax) and hypomethylating agents to treat adult patients who have acute myeloid leukemia (AML). The EMA is expected to make the final decision before the end of H1 2020. AbbVie Inc. (NYSE:ABBV) also announced more recently that it filed applications for SKYRIZI’s approval by the EMA and the FDA. The submissions were accompanied by favorable findings from Phase 3 studies.
The FDA accepted an NDA for a calcitonin gene-related peptide (CGRP) receptor antagonist (gepant) called atogepant as a potential preventative drug for migraines. The FDA is expected to reveal its decision in Q3.